ACTRN12618000566235
Active, not recruiting
Phase 2
Ablative Stereotactic Radiotherapy as an alternative to systemic treatment in men with oligometastatic prostate cancer and controlled primary disease. A prospective Phase II study measuring toxicity, disease control and freedom from escalation in systemic therapy
Integrated Clinical Oncology Network Pty Ltd (ICON)0 sites208 target enrollmentApril 13, 2018
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Integrated Clinical Oncology Network Pty Ltd (ICON)
- Enrollment
- 208
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologically confirmed diagnosis of prostate cancer.
- •\- Biochemical relapses of prostate cancer following radical local treatment.
- •\- Males aged 18 years to 80 years inclusive.
- •\- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1\.
- •\- N1 and M1 a/b disease on imaging, with a combined maximum of five synchronous lesions
- •\- Exclusion of local relapse.
- •\- Metastases suitable for ablative radiotherapy
Exclusion Criteria
- •\- No prior palliative radiotherapy (definitive radiotherapy as part of initial management is allowed).
- •\- Active local disease on clinical examination.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): A Randomized Phase II Trialcancer spread to other parts of the bodymetastatic cancer10027476NL-OMON37922Vrije Universiteit Medisch Centrum20
Withdrawn
Not Applicable
Stereotactic Ablative Radiotherapy (SAbR) for Treatment of Ventricular Tachycardia (VT) Refractory Standard Invasive Ablation TechniquesTachycardia, VentricularNCT04334811University of Texas Southwestern Medical Center
Completed
Not Applicable
Stereotactic ablative radiotherapy (SABR) for small lung tumors: retrospective analysis 2009-2010C34C78.0Malignant neoplasm of bronchus and lungSecondary malignant neoplasm of lungDRKS00003864niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde39
Not yet recruiting
Not Applicable
Mapping guided Stereotactic ablative RadiotherapyNL-OMON27436Departments of Cardiology and Radiotherapy, Leiden University Medical Center12
Recruiting
Not Applicable
Mapping guided Stereotactic ablative Radiotherapy, Hybrid treatment for uncontrollable ventricular tachycardiaNL-OMON52679eids Universitair Medisch Centrum12